An open label, multicentre study of the EVRA (norelgestromin/ethinyl estradiol) transdermal contraceptive patch in Europe: evaluation of women's experience with EVRA and comparison with previously used methods of contraception
Phase of Trial: Phase IV
Latest Information Update: 19 Oct 2007
At a glance
- Drugs Ethinylestradiol/norelgestromin (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutica
- 19 Oct 2007 Status changed from in progress to completed.
- 07 Jul 2007 New trial record.